MCM
ABBV icon

McKinley Capital Management’s AbbVie ABBV Stock Holding History

McKinley Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,579
Closed -$2.32M – 160
2023
Q1 		$2.32M Sell
14,579
-364
-2% -$55.6K 0.31% 92
2022
Q4 		$2.41M Sell
14,943
-123
-0.8% -$18.9K 0.32% 92
2022
Q3 		$2.02M Buy
15,066
+4,503
+43% +$646K 0.27% 100
2022
Q2 		$1.62M Buy
+10,563
New +$1.61M 0.21% 113
2018
Q3 		– Sell
-251,038
Closed -$23.3M – 286
2018
Q2 		$23.3M Sell
251,038
-61,581
-20% -$6.01M 1.51% 22
2018
Q1 		$29.6M Sell
312,619
-21,038
-6% -$2.31M 1.73% 18
2017
Q4 		$32.3M Buy
333,657
+94,985
+40% +$8.95M 1.63% 12
2017
Q3 		$21.2M Buy
238,672
+179,405
+303% +$13.7M 0.87% 43
2017
Q2 		$4.3M Sell
59,267
-10,216
-15% -$687K 0.16% 103
2017
Q1 		$4.53M Sell
69,483
-15,872
-19% -$998K 0.17% 96
2016
Q4 		$5.34M Sell
85,355
-74,174
-46% -$4.53M 0.21% 88
2016
Q3 		$10.1M Buy
159,529
+32,047
+25% +$2.07M 0.36% 73
2016
Q2 		$7.89M Sell
127,482
-1,742
-1% -$106K 0.38% 83
2016
Q1 		$7.38M Buy
129,224
+11,029
+9% +$615K 0.36% 76
2015
Q4 		$7M Sell
118,195
-6,906
-6% -$398K 0.32% 80
2015
Q3 		$6.81M Sell
125,101
-506
-0.4% -$32.9K 0.33% 83
2015
Q2 		$8.44M Sell
125,607
-7,639
-6% -$499K 0.36% 76
2015
Q1 		$7.8M Sell
133,246
-12,107
-8% -$731K 0.31% 89
2014
Q4 		$9.51M Sell
145,353
-778
-0.5% -$49K 0.38% 73
2014
Q3 		$8.44M Buy
146,131
+16,325
+13% +$906K 0.37% 79
2014
Q2 		$7.33M Sell
129,806
-21,474
-14% -$1.13M 0.3% 86
2014
Q1 		$7.78M Sell
151,280
-68
-0% -$3.44K 0.33% 78
2013
Q4 		$7.99M Buy
151,348
+12,445
+9% +$612K 0.31% 76
2013
Q3 		$6.21M Sell
138,903
-5,501
-4% -$244K 0.27% 92
2013
Q2 		$5.97M Buy
+144,404
New +$6.32M 0.3% 73

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

McKinley Capital Management's ABBV Position: Q2 2023 in Review

McKinley Capital Management sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 14,579 shares — an estimated $2.32M sold.

McKinley Capital Management first reported a position in ABBV in Q2 2013 and held it in 25 quarters. The position peaked at $32.3M in Q4 2017. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • McKinley Capital Management reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • McKinley Capital Management sold 14,579 AbbVie shares in Q2 2023, an estimated $2.32M.
  • McKinley Capital Management first reported a position in AbbVie in Q2 2013 and held it in 25 quarters.
  • McKinley Capital Management's AbbVie position peaked at $32.3M in Q4 2017.
  • 3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on McKinley Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.